Sofinnova

Press

Featured Portfolio News

Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts
Lisata Therapeutics Announced Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement

Lisata Therapeutics Announced Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement

Sep 17, 2026
# Portfolio News
link
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

Sep 4, 2026
# Portfolio News
link
Expedition Announced Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPD

Expedition Announced Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPD

Aug 5, 2026
# Portfolio News
link
Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts

All Portfolio News

All Years #
All Years
2026
2025
2024
2023
2022
2021

Jul 28, 2026

Claris Bio Unveils Development Strategy and Planned Pivotal Study Supported by $118 Million Series B Financing

# Portfolio News
#
link

Jul 7, 2026

Vera Received FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy

# Portfolio News
#
link

Jul 6, 2026

Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio

# Portfolio News
#
link

Jun 8, 2026

City Therapeutics Announces $99.5 Million Series B Financing to Advance Next-Generation RNAi Therapeutics

# Portfolio News
#
link

Jun 8, 2026

Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders

# Portfolio News
#
link

Jun 1, 2026

Avenzo Therapeutics and Rallybio Corporation Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement

# Portfolio News
#
link

May 18, 2026

Baxfendy Approved in the US as the First and Only Aldosterone Synthase Inhibitor Treatment for Adults with Hypertension

# Portfolio News
#
link

Apr 30, 2026

Seaport Therapeutics Announced Pricing of Upsized Initial Public Offering

# Portfolio News
#
link

Apr 28, 2026

Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline

# Portfolio News
#
link

Apr 21, 2026

Avenzo Therapeutics to Present Updated Results from the Phase 1 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2026 American Society of Clinical Oncology Annual Meeting

# Portfolio News
#
link

Apr 21, 2026

Star Therapeutics Receives FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VGA039 in Von Willebrand Disease Prophylaxis

# Portfolio News
#
link

Apr 2, 2026

Seaport Announced Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers

# Portfolio News
#
link

Mar 9, 2026

Rapport and Tenacia Biotechnology Announced Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China

# Portfolio News
#
link
Load More  

Featured Perspectives

Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts
James Healy Shares His Perspective on the Importance of Building the Right Foundation Examining the Next Wave of Biotech IPOs in PharmaVoice

James Healy Shares His Perspective on the Importance of Building the Right Foundation Examining the Next Wave of Biotech IPOs in PharmaVoice

Sep 17, 2026
# Perspectives
link
Maha Katabi Chats with BioSpace: Steady Stream of Crossover Rounds Stock Biotech’s IPO Pipeline

Maha Katabi Chats with BioSpace: Steady Stream of Crossover Rounds Stock Biotech’s IPO Pipeline

Sep 9, 2026
# Perspectives
link
Maha Katabi Weighs In on the Rise of Biopharma Reverse Mergers with BioSpace

Maha Katabi Weighs In on the Rise of Biopharma Reverse Mergers with BioSpace

Sep 3, 2026
# Perspectives
link
Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts

All Perspectives

All Years #
All Years
2026
2025
2024

Aug 6, 2026

Jim Healy in Life Science Leader Guest Column: Innovation, Not Scale, Will Define Pharma’s Next Decade

# Perspectives
#
link

Jul 22, 2026

Jim Healy Featured in BioCentury Op-ed “The Next 50 Years Won’t Be Defined by Borders”

# Perspectives
#
link

Jul 22, 2026

Maha Radhakrishnan Talks with BioSpace on AI Data Becomes Sticking Point in Biopharma Dealmaking

# Perspectives
#
link

Jul 13, 2026

Jakob Dupont Shared with BioSpace Why the Next Generation of ADCs Must Deliver Both Efficacy and Tolerability Not As a Tradeoff But Together.

# Perspectives
#
link

Jul 6, 2026

Maha Radhakrishnan Joined Ben Comer of Life Science Leader’s Business Biotech Podcast

# Perspectives
#
link

Jul 3, 2026

Jakob Dupont Provided the Investor Perspective with BioXconomy “The Mega-Round Mindset: How Biotechs are Thinking Bigger and Raising Smarter”

# Perspectives
#
link

Jul 1, 2026

Jakob Dupont Noted In Endpoints News Discussion During BIO2026 “A June Flourish Lifts Biotech Megaround Tally in First Half of 2026”

# Perspectives
#
link

Jul 1, 2026

Maha Radhakrishnan Chats with BioSpace During #BIO2026: “BIO Outshines World Cup as Biotech Celebrates 50th Anniversary With A Call To Action”

# Perspectives
#
link

Jun 29, 2026

Jim Healy Weighs In on AI Drug Discovery Trends with Brian Gormley at WSJ

# Perspectives
#
link

Jun 26, 2026

Maha Radhakrishnan Speaks with BioSpace at BIO 2026: Forget Dual Track—Biopharma Deals Are More Complex Than Ever

# Perspectives
#
link

Jun 25, 2026

Jim Healy Explains At #BIO2026 Why This is a Terrific Time To Be In The Industry

# Perspectives
#
link

Jun 24, 2026

Jakob Dupont Featured in BioSpace Ahead of BIO2026 Panel “Can ADCs be kinder and gentler? Join BioSpace at BIO to Find Out

# Perspectives
#
link

Jun 23, 2026

Jim Healy Shares His Thoughts with BiotechTV on the Current State of Biotech at BIO2026

# Perspectives
#
link
Load More  

Featured Sofinnova News

Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts
We’re Pleased to Welcome Merdad Parsey, M.D., Ph.D.

We’re Pleased to Welcome Merdad Parsey, M.D., Ph.D.

Sep 9, 2026
# Sofinnova News
link
Jonathan Leff Featured in The Venture Network Top 10 Biotech Investors to Watch: Innovation, Science, Impact

Jonathan Leff Featured in The Venture Network Top 10 Biotech Investors to Watch: Innovation, Science, Impact

Aug 3, 2026
# Sofinnova News
link
Sofinnova Investments Announces the Addition of Dr. Maha Radhakrishnan as Executive Partner

Sofinnova Investments Announces the Addition of Dr. Maha Radhakrishnan as Executive Partner

Aug 6, 2024
# Sofinnova News
link
Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts

All Sofinnova News

All Years #
All Years
2026
2025
2024
2023
2022
2021

Apr 2, 2025

Atsena Announced Oversubscribed $150 Million Series C Financing to Further Advance Ocular Gene Therapy Programs

# Sofinnova News
#
link

Mar 27, 2024

Maha Katabi Featured in NVCA Member Spotlight

# Sofinnova News
#
link

Mar 12, 2024

Sofinnova Investments Appoints Troy Ignelzi as Executive Advisor

# Sofinnova News
#
link

Feb 16, 2024

Maha Katabi Speaks with Endpoints News on Recent M&A, IPO, and Deal Flow Activity

# Sofinnova News
#
link

Jan 11, 2024

Jim Healy Shares Perspective on What’s Driving M&A Optimism for 2024 with WSJ

# Sofinnova News
#
link

Dec 13, 2023

BioSpace Reporter Tyler Patchen Spoke with Jakob Dupont and Other Industry Professionals for Advice on How to Optimize Time at JPM Healthcare Conference

# Sofinnova News
#
link

Nov 27, 2023

Maha Katabi Named One of Fierce Biotech’s 2023’s Fiercest Women in Life Sciences

# Sofinnova News
#
link

May 16, 2023

Sofinnova Welcomes Dr. Jakob Dupont as Executive Partner

# Sofinnova News
#
link

Mar 22, 2023

Sofinnova Supporting Female Biotech Executives

# Sofinnova News
#
link

Mar 15, 2023

Regina Salvat Featured in Biomarker: “23 Biotech VCs in ’23”

# Sofinnova News
#
link

Dec 1, 2022

Maha Katabi Featured in BioWorld: “Venture Financing: Less Zoom but Still Plenty of Capital in Correcting Market”

# Sofinnova News
#
link

Apr 5, 2022

Sofinnova Investments Announces the Addition of Dr. Chris Carpenter as Executive Partner

# Sofinnova News
#
link

Mar 15, 2022

Regina Salvat Selected by Venture Forward as One of Ten Women in VC: Rising Stars to Watch

# Sofinnova News
#
link
Load More  

Featured Events

Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts
Maha Radhakrishnan to join “Breakthrough Developments in CNS” panel during Nordic Life Science Days on September 8th at 11:15AM

Maha Radhakrishnan to join “Breakthrough Developments in CNS” panel during Nordic Life Science Days on September 8th at 11:15AM

Jul 16, 2026
# Events
link
Our Team Will Join a Series of Discussions at BIO: From Biotech Financing, Global Dealmaking, Neuroscience, Oncology, to the Future of Innovation June 22-25 in San Diego

Our Team Will Join a Series of Discussions at BIO: From Biotech Financing, Global Dealmaking, Neuroscience, Oncology, to the Future of Innovation June 22-25 in San Diego

Jun 17, 2026
# Events
link
Jakob Dupont to Join ‘In Vivo CAR Race: Delivery Vehicles Compete to Solve Cell Therapy’s Need for Scale” Panel At BioCentury Grand Rounds on June 5th at 1:30pm PT

Jakob Dupont to Join ‘In Vivo CAR Race: Delivery Vehicles Compete to Solve Cell Therapy’s Need for Scale” Panel At BioCentury Grand Rounds on June 5th at 1:30pm PT

May 22, 2026
# Events
link
Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts

All Events

All Years #
All Years
2026
2025
2024
2023
2022
2021

May 29, 2026

Troy Ignelzi to Join “Impact Investing and Investments to drive Brain Innovations and Economy” Panel At Texas Brain Economy Summit on June 9th at 1:00pm CT

# Events
#
link

May 29, 2026

Jakob Dupont to Join “Translating Science to Brain Ventures” Panel At Texas Brain Economy Summit on June 10th at 1:20pm CT

# Events
#
link

Apr 23, 2026

Maha Katabi To Join “The Next Wave of Health Innovation” at Milken Global Conference 2026 on May 4 at 2:30pm PT

# Events
#
link

Apr 10, 2026

Jakob Dupont to Join “M&A in 2026: The Year Pharma Deals Change the Game” Panel During Fierce Pharma Engage on April 23rd at 11:20am PT

# Events
#
link

Mar 30, 2026

Jakob Dupont to Join “What Investors are Looking For in 2026” Panel During CMO Summit 360 on April 14th at 10:25am ET

# Events
#
link

Mar 20, 2026

Maha Radhakrishnan Joins as Keynote Speaker for “Module 1: Values-Driven Leadership Essentials” of Termeer Ascend in Partnership with MassBio on April 12th at 12pm ET

# Events
#
link

Mar 1, 2026

Jakob Dupont to Join ” Advancing the Next Generation of Large Molecule Innovation” Panel During Fierce Pharma Drug Development & Delivery Day on March 31st at 1:55pm ET

# Events
#
link

Jan 14, 2026

Maha Katabi to Join “Biotech’s Capital Gambit: IPOs, Private Paths and the Road Ahead” Panel During Fierce JPM Week 2026 on Jan. 14 at 9:40am PT

# Events
#
link

Jan 14, 2026

Maha Radhakrishnan to Join “Shaping the Future of Brain Health: Strategic Innovation in CNS Therapeutics” Panel During Biotech Showcase on Jan. 14 at 8am PT

# Events
#
link

Jan 14, 2026

Jim Healy To Join “The Outlook for Biopharma Financing: Where is the Funding Going?” Panel During Biotech Showcase on Jan. 14 at 12pm PT

# Events
#
link

Sep 11, 2025

Maha Radhakrishnan To Join “Thinking like an Investor: The Risk-Adjusted Cost of Generating Value in R&D: During LSX Boston On Sept. 17 at 11am ET

# Events
#
link

May 21, 2025

Jakob Dupont to Join “Preparing for an IPO: Best Practices for Success” Panel During BIO 2025 on June 16th at 3PM ET

# Events
#
link

May 20, 2025

Maha Radhakrishnan to Speak at “The Investment Heat Map: Where Capital’s Surging—and Where It’s Not” at CHPI Americas on May 20th at 10:25 ET

# Events
#
link
Load More  

Featured Videos and Podcasts

Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts
Sofinnova Portfolio Spotlight: A Conversation with Rapport Therapeutics

Sofinnova Portfolio Spotlight: A Conversation with Rapport Therapeutics

Sep 14, 2026
# Videos & Podcasts
link
Portfolio News
Perspectives
Sofinnova News
Events
Videos and Podcasts